- Home
- INTT vs FENC Comparison
INTT vs FENC Comparison
Compare INTT & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INTT | FENC |
|---|---|---|
| Founded | 1981 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 234.0M | 230.8M |
| IPO Year | 1997 | 2010 |
Fundamental Metrics
Financial Performance| Metric | INTT | FENC |
|---|---|---|
| Price | $13.93 | $10.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $13.50 | ★ $14.50 |
| AVG Volume (30 Days) | ★ 223.9K | 193.6K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.06 | 0.01 |
| Revenue | ★ $66,801,000.00 | $44,642,000.00 |
| Revenue This Year | $15.82 | $65.12 |
| Revenue Next Year | $9.10 | $41.08 |
| P/E Ratio | ★ $245.00 | $1,015.00 |
| Revenue Growth | ★ 66.06 | N/A |
| 52 Week Low | $6.63 | $5.65 |
| 52 Week High | $20.00 | $11.31 |
Technical Indicators
Market Signals| Indicator | INTT | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 40.92 | 48.70 |
| Support Level | $12.75 | $10.04 |
| Resistance Level | $15.45 | $10.45 |
| Average True Range (ATR) | 0.97 | 0.56 |
| MACD | -0.01 | -0.12 |
| Stochastic Oscillator | 41.94 | 20.07 |
Price Performance
Historical ComparisonAbout INTT inTest Corporation
inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.